Department of Biopharmaceutical Engineering, Dongguk University-WISE, Gyeongju 38066, Republic of Korea.
Nutrients. 2023 Dec 13;15(24):5092. doi: 10.3390/nu15245092.
Gastric cancer is one of the most prevalent cancer types worldwide, and its resistance to cancer therapies, such as chemotherapy and radiotherapy, has made treating it a major challenge. Paeoniflorin (PF) is one potential pharmacological treatment derived from paeony root. However, in cancer, the molecular mechanisms and biological functions of PF are still unclear. In the present study, we found that PF exerts anti-tumor effects in vivo and in vitro and induces apoptotic cell death through ER stress, calcium (Ca), and reactive oxygen species (ROS) release in gastric cancer cells. However, ROS inhibition by DPI and NAC blocks cell death and the PERK signaling pathway via the reduction of Nox4. Moreover, PF triggers a synergistic inhibitory effect of the epithelial-mesenchymal transition (EMT) process under radiation exposure in radiation-resistant gastric cancer cells. These findings indicate that PF-induced Ca and ROS release overcomes radioresistance via ER stress and induces cell death under radiation in gastric cancer cells. Therefore, PF, in combination with radiation, may be a powerful strategy for gastric cancer therapy.
胃癌是全球最常见的癌症类型之一,其对化疗和放疗等癌症疗法的耐药性使得治疗成为一个主要挑战。芍药苷(PF)是一种源自芍药根的潜在药物治疗方法。然而,在癌症中,PF 的分子机制和生物学功能仍不清楚。在本研究中,我们发现 PF 在体内和体外均具有抗肿瘤作用,并通过诱导胃癌细胞内质网应激、钙离子(Ca)和活性氧(ROS)释放来诱导细胞凋亡。然而,通过 DPI 和 NAC 抑制 ROS 会通过减少 Nox4 来阻断细胞死亡和 PERK 信号通路。此外,PF 在辐射抗性胃癌细胞中触发辐射下上皮-间充质转化(EMT)过程的协同抑制作用。这些发现表明,PF 诱导的 Ca 和 ROS 释放通过内质网应激克服放射抵抗,并在胃癌细胞中诱导放射下的细胞死亡。因此,PF 联合放疗可能是治疗胃癌的有力策略。